Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum Sensitive Ovarian Cancer Patients

Full Text View

This study is currently recruiting participants.

Verified December 2012 by Bristol-Myers Squibb 

 

Sponsor:

Bristol-Myers Squibb

Information provided by (Responsible Party):

Bristol-Myers Squibb

ClinicalTrials.gov Identifier:

NCT01611558

 

First received: May 25, 2012

Last updated: December 7, 2012

Last verified: December 2012

History of Changes